W H Wilson Tang1,2, Jennifer D Wilcox2, Miriam S Jacob1, Erika B Rosenzweig3, Barry A Borlaug4, Robert P Frantz4, Paul M Hassoun5, Anna R Hemnes6, Nicholas S Hill7, Evelyn M Horn8, Harsimran S Singh8, David M Systrom9, Ryan J Tedford10, Rebecca R Vanderpool11,12, Aaron B Waxman9, Lei Xiao13, Jane A Leopold14, Franz P Rischard15. 1. Division of Heart Failure & Transplant Medicine, Department of Cardiovascular Medicine (W.H.W.T., M.S.J.), Cleveland Clinic, Cleveland, OH. 2. Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute (W.H.W.T., J.D.W.), Cleveland Clinic, Cleveland, OH. 3. Division of Pediatric Cardiology, Department of Pediatrics and Medicine, Columbia University Medical Center, New York, NY (E.B.R.). 4. Division of Circulatory Failure, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (B.A.B., R.P.F.). 5. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD (P.M.H.). 6. Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (A.R.H.). 7. Department of Pulmonary, Critical Care and Sleep Medicine, Tufts University Medical Center, Boston MA (N.S.H.). 8. Division of Cardiology, Department of Medicine, Cornell University Medical Center, New York, NY (E.M.H., H.S.S.). 9. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (D.M.S., A.B.W.). 10. Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC (R.J.T.). 11. Division of Translational and Regenerative Medicine, (R.R.V.). 12. University of Arizona College of Medicine, Tucson, AZ (R.R.V.). 13. National Heart, Lung and Blood Institute, Bethesda MD (L.X.). 14. Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston MA (J.A.L.). 15. Division of Pulmonary, Allergy, Critical Care & Sleep Medicine, Department of Medicine (F.P.R.).
Abstract
BACKGROUND: Invasive hemodynamic evaluation through right heart catheterization plays an essential role in the diagnosis, categorization, and risk stratification of patients with pulmonary hypertension. METHODS: Subjects enrolled in the PVDOMICS (Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics) program undergo an extensive invasive hemodynamic evaluation that includes repeated measurements at rest and during several provocative physiological challenges. It is a National Institutes of Health/National Heart, Lung, and Blood Institute initiative to reclassify pulmonary hypertension groups based on clustered phenotypic and phenomic characteristics. At a subset of centers, participants also undergo an invasive cardiopulmonary exercise test to assess changes in hemodynamics and gas exchange during exercise. CONCLUSIONS: When coupled with other physiological testing and blood -omic analyses involved in the PVDOMICS study, the comprehensive right heart catheterization protocol described here holds promise to clarify the diagnosis and clustering of pulmonary hypertension patients into cohorts beyond the traditional 5 World Symposium on Pulmonary Hypertension groups. This article will describe the methods applied for invasive hemodynamic characterization in the PVDOMICS program. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02980887.
BACKGROUND: Invasive hemodynamic evaluation through right heart catheterization plays an essential role in the diagnosis, categorization, and risk stratification of patients with pulmonary hypertension. METHODS: Subjects enrolled in the PVDOMICS (Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics) program undergo an extensive invasive hemodynamic evaluation that includes repeated measurements at rest and during several provocative physiological challenges. It is a National Institutes of Health/National Heart, Lung, and Blood Institute initiative to reclassify pulmonary hypertension groups based on clustered phenotypic and phenomic characteristics. At a subset of centers, participants also undergo an invasive cardiopulmonary exercise test to assess changes in hemodynamics and gas exchange during exercise. CONCLUSIONS: When coupled with other physiological testing and blood -omic analyses involved in the PVDOMICS study, the comprehensive right heart catheterization protocol described here holds promise to clarify the diagnosis and clustering of pulmonary hypertension patients into cohorts beyond the traditional 5 World Symposium on Pulmonary Hypertension groups. This article will describe the methods applied for invasive hemodynamic characterization in the PVDOMICS program. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02980887.
Authors: Mads J Andersen; Thomas P Olson; Vojtech Melenovsky; Garvan C Kane; Barry A Borlaug Journal: Circ Heart Fail Date: 2014-10-23 Impact factor: 8.790
Authors: Barry A Borlaug; Rick A Nishimura; Paul Sorajja; Carolyn S P Lam; Margaret M Redfield Journal: Circ Heart Fail Date: 2010-06-11 Impact factor: 8.790
Authors: Yogesh N V Reddy; Thomas P Olson; Masaru Obokata; Vojtech Melenovsky; Barry A Borlaug Journal: JACC Heart Fail Date: 2018-05-23 Impact factor: 12.035
Authors: Gregory D Lewis; Ryan M Murphy; Ravi V Shah; Paul P Pappagianopoulos; Rajeev Malhotra; Kenneth D Bloch; David M Systrom; Marc J Semigran Journal: Circ Heart Fail Date: 2011-02-03 Impact factor: 8.790
Authors: Tufik R Assad; Bradley A Maron; Ivan M Robbins; Meng Xu; Shi Huang; Frank E Harrell; Eric H Farber-Eger; Quinn S Wells; Gaurav Choudhary; Anna R Hemnes; Evan L Brittain Journal: JAMA Cardiol Date: 2017-12-01 Impact factor: 14.676
Authors: Rebecca R Vanderpool; Kendall S Hunter; Michael Insel; Joe G N Garcia; Edward J Bedrick; Ryan J Tedford; Franz P Rischard Journal: Chest Date: 2021-10-09 Impact factor: 10.262
Authors: William M Oldham; Anna R Hemnes; Micheala A Aldred; John Barnard; Evan L Brittain; Stephen Y Chan; Feixiong Cheng; Michael H Cho; Ankit A Desai; Joe G N Garcia; Mark W Geraci; Susan D Ghiassian; Kathryn T Hall; Evelyn M Horn; Mohit Jain; Rachel S Kelly; Jane A Leopold; Sara Lindstrom; Brian D Modena; William C Nichols; Christopher J Rhodes; Wei Sun; Andrew J Sweatt; Rebecca R Vanderpool; Martin R Wilkins; Beth Wilmot; Roham T Zamanian; Joshua P Fessel; Neil R Aggarwal; Joseph Loscalzo; Lei Xiao Journal: J Am Coll Cardiol Date: 2021-04-27 Impact factor: 27.203
Authors: Min Li; Suzette Riddle; Sushil Kumar; Joanna Poczobutt; B Alexandre McKeon; Maria G Frid; Maureen Ostaff; Julie A Reisz; Travis Nemkov; Mehdi A Fini; Aya Laux; Cheng-Jun Hu; Karim C El Kasmi; Angelo D'Alessandro; R Dale Brown; Hui Zhang; Kurt R Stenmark Journal: Front Immunol Date: 2021-03-31 Impact factor: 7.561
Authors: Michael H Lee; Thaís C F Menezes; Julie A Reisz; Eloara V M Ferreira; Brian B Graham; Rudolf K F Oliveira Journal: Front Physiol Date: 2022-09-12 Impact factor: 4.755
Authors: Christine L Jellis; Margaret M Park; Aiden Abidov; Barry A Borlaug; Evan L Brittain; Robert Frantz; Paul M Hassoun; Evelyn M Horn; Wael A Jaber; Kim Jiwon; Maria G Karas; Deborah Kwon; Jane A Leopold; Bradley Maron; Stephen C Mathai; Reena Mehra; Franz Rischard; Erika B Rosenzweig; W H Wilson Tang; Rebecca Vanderpool; James D Thomas Journal: Eur Heart J Cardiovasc Imaging Date: 2022-06-21 Impact factor: 9.130